Novugen Pharma Malaysia Sdn Bhd, based in U.A.E, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is FINGOLIMOD HYDROCHLORIDE USP, with a corresponding US DMF Number 33328.
Remarkably, this DMF maintains an Active status since its submission on December 24, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 02, 2019, and payment made on January 28, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II